Printed From:

LANTUS® DOSAGE AND ADMINISTRATION

Interactive T2DM dosing calculator


Enter the weight to calculate the suggested starting dose for your insulin-naive patients starting Lantus® Please enter a weight between 110 lb and 505 lb
lb
/ 0

Invalid Number Please enter a weight between 110 lbs and 505 lbs

Initiating Lantus® in insulin-naive and switched patients

Patients with T2DM: Lantus® dosing

  • The recommended starting dose of Lantus® in patients with type 2 diabetes who are not currently treated with insulin is 0.2 Units/kg or up to 10 Units once daily, adjusted to patient’s appropriate FPG target. One may need to adjust the amount and timing of short- or rapid-acting insulins and dosages of any oral anti-diabetic drugs

Patients with T1DM: Start Lantus® at an appropriate dose for each patient

  • The recommended starting dose of Lantus® should be approximately 1/3 of the total daily insulin requirements
  • Lantus® must be used with a short-acting insulin

Other dosing information

  • Individualize and adjust the dosage of Lantus® based on the individual’s metabolic needs, blood glucose monitoring results, and glycemic control goal
  • Administer Lantus® subcutaneously once a day at any time of the day, but at the same time every day
  • Converting from other insulin therapies may require adjustment of timing and dose of Lantus®
  • Closely monitor glucose values, especially upon converting to Lantus® and during the initial weeks thereafter
  • Dosage adjustments may be needed with changes in physical activity, changes in meal patterns, during acute illness, or changes in renal or hepatic function
 

Get samples for your patients

Register for Samples

 
 

Lantus® Savings Offers Commercially insured patients pay as low as $0 and no more than $99* for a 30-day supply. For patients without insurance there is an offer too. Terms and Eligibility Restrictions Apply.See Below* SEE OFFERS

 

*Eligibility Restrictions & Offer Terms:

Insulins Valyou Savings Program: Sanofi insulins included in this program are: ADMELOG® (insulin lispro injection) 100 Units/mL, TOUJEO® (insulin glargine injection) 300 Units/mL, LANTUS® (insulin glargine injection) 100 Units/mL and APIDRA® (insulin glulisine injection) 100 Units/mL.

This offer is not valid for prescriptions covered by or submitted for reimbursement under Medicare, Medicaid, VA, DOD, TRICARE, similar federal or state programs, including any state pharmaceutical programs, or commercial / private insurance. Only people without prescription medication insurance can apply for this offer. Void where prohibited by law. For the duration of the program, eligible patients will pay $99 for up to 10 vials or packs of pens per fill. Offer valid for one fill per month. To pay $99 per month, you must fill all your Sanofi Insulin prescriptions at the same time, together each month. Not valid for SOLIQUA 100/33 (insulin glargine and lixisenatide injection) 100 Units/mL and 33 mcg/mL or Toujeo Max SoloStar pen. When using the Insulins Valyou Savings Card, prices are guaranteed for 12 consecutive monthly fills. The Insulins Valyou Savings Program applies to the cost of medication. There are other relevant costs associated with overall treatment

Sanofi Copay Program: This offer is not valid for prescriptions covered by or submitted for reimbursement under Medicare, Medicaid, VA, DOD, TRICARE, or similar federal or state programs including any state pharmaceutical assistance program. If you have an Affordable Care (Health Care Exchange) plan, you may still be qualified to receive and use this savings card. Please note: the Federal Employees Health Benefits (FEHB) Program is not a federal or state government health care program for purposes of the savings program. Void where prohibited by law.

  • Lantus: pay as low as $0 up to $99 for a 30-day supply, depending on insurance coverage. Maximum savings apply. Valid up to 10 packs per fill; Offer valid for one fill per month per 30-day supply

Savings may vary depending on patients' out-of-pocket costs. Upon registration, patients receive all program details. Sanofi US reserves the right to change the maximum cap amount, rescind, revoke or amend these programs without notice.

Reference:

Lantus® Prescribing Information.

All registered trademarks cited are property of their respective owners.